← Eichor
Study identifier: NCT05715710 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Correlation Between Deep Medullary Veins and Cognitive Dysfunction in Cerebral Small Vessel Disease

Condition: Cerebral Small Vessel Disease  ·  Sponsor: Zigong No.1 Peoples Hospital

PhaseN/A
Planned participants200
Who can joinAll sexes, 50 Years to 85 Years
Healthy volunteersYes

About this study

This study aims to obtain the characteristics of cognitive impairment and imaging characteristics of patients with Cerebral small vessel disease (CSVD) through comprehensive and standardized neuropsychological assessment and multimodal imaging examination. The focus is to obtain the characteristics of cognitive impairment and imaging characteristics of patients with CSVD through 3.0T MRI SWI sequence. deep medullary veins (DMVs) were measured. To compare the demographic data, hematological indexes, imaging scores and the number of DMVs between CSVD groups with and without cognitive impairment, and to explore the correlation between deep medullary veins and cognitive dysfunction in cerebral small vessel disease.

This description comes directly from the study's public registry record.

Talk to the study team

ya x Xu  ·  15983171312  ·  502687651@qq.com

ling zhao  ·  13679076409  ·  1628583742@qq.com

Always discuss trial participation with your own doctor first.

Locations (1)

Zigong First People's HospitalZigong, Sichuan, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05715710